Your browser doesn't support javascript.
loading
The International Association for the Study of Lung Cancer (IASLC) Staging Project for Lung Cancer: Recommendation to Introduce Spread Through Air Spaces as a Histologic Descriptor in the Ninth Edition of the TNM Classification of Lung Cancer. Analysis of 4061 Pathologic Stage I NSCLC.
Travis, William D; Eisele, Megan; Nishimura, Katherine K; Aly, Rania G; Bertoglio, Pietro; Chou, Teh-Ying; Detterbeck, Frank C; Donnington, Jessica; Fang, Wentao; Joubert, Philippe; Kernstine, Kemp; Kim, Young Tae; Lievens, Yolande; Liu, Hui; Lyons, Gustavo; Mino-Kenudson, Mari; Nicholson, Andrew G; Papotti, Mauro; Rami-Porta, Ramon; Rusch, Valerie; Sakai, Shuji; Ugalde, Paula; Van Schil, Paul; Yang, Chi-Fu Jeffrey; Cilento, Vanessa J; Yotsukura, Masaya; Asamura, Hisao.
Afiliação
  • Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: travisw@mskcc.org.
  • Eisele M; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
  • Nishimura KK; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
  • Aly RG; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Bertoglio P; IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
  • Chou TY; Department of Pathology and Laboratory Medicine, Taipei, Veterans General Hospital, Taipei, Taiwan.
  • Detterbeck FC; Department of Surgery, Yale University, New Haven, Connecticut.
  • Donnington J; University of Chicago, Chicago, Illinois.
  • Fang W; Department of Thoracic Surgery, Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China.
  • Joubert P; Institut Universitaire de Cardiologie et de Pneumologie de Quebec - Université Laval, Quebec City, Canada.
  • Kernstine K; Department of Cardiovascular and Thoracic Surgery, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Kim YT; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lievens Y; Radiation Oncology, Ghent University Hospital and Ghent University, Gent, Belgium.
  • Liu H; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangdong, People's Republic of China.
  • Lyons G; Buenos Aires British Hospital, Buenos Aires, Argentina.
  • Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Nicholson AG; Department of Histopathology, Royal Brompton Hospital, London, United Kingdom.
  • Papotti M; Department of Oncology, University of Turin, Torino, Italy.
  • Rami-Porta R; Department of Thoracic Surgery, Hospital Universitari Mútua Terrassa, University of Barcelona, and CIBERES Lung Cancer Group, Terrassa, Barcelona, Spain.
  • Rusch V; Thoracic Surgery Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Sakai S; Tokyo Women's Medical University, Tokyo, Japan.
  • Ugalde P; Brigham & Women's Hospital, Boston, Massachusetts.
  • Van Schil P; Antwerp University and Antwerp University Hospital, (Edegem) Antwerp, Belgium.
  • Yang CJ; Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts.
  • Cilento VJ; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
  • Yotsukura M; Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Asamura H; Department of Thoracic Surgery, Keio University, Tokyo, Japan.
J Thorac Oncol ; 19(7): 1028-1051, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38508515
ABSTRACT

INTRODUCTION:

Spread through air spaces (STAS) consists of lung cancer tumor cells that are identified beyond the edge of the main tumor in the surrounding alveolar parenchyma. It has been reported by meta-analyses to be an independent prognostic factor in the major histologic types of lung cancer, but its role in lung cancer staging is not established.

METHODS:

To assess the clinical importance of STAS in lung cancer staging, we evaluated 4061 surgically resected pathologic stage I R0 NSCLC collected from around the world in the International Association for the Study of Lung Cancer database. We focused on whether STAS could be a useful additional histologic descriptor to supplement the existing ones of visceral pleural invasion (VPI) and lymphovascular invasion (LVI).

RESULTS:

STAS was found in 930 of 4061 of the pathologic stage I NSCLC (22.9%). Patients with tumors exhibiting STAS had a significantly worse recurrence-free and overall survival in both univariate and multivariable analyses involving cohorts consisting of all NSCLC, specific histologic types (adenocarcinoma and other NSCLC), and extent of resection (lobar and sublobar). Interestingly, STAS was independent of VPI in all of these analyses.

CONCLUSIONS:

These data support our recommendation to include STAS as a histologic descriptor for the Ninth Edition of the TNM Classification of Lung Cancer. Hopefully, gathering these data in the coming years will facilitate a thorough analysis to better understand the relative impact of STAS, LVI, and VPI on lung cancer staging for the Tenth Edition TNM Stage Classification.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Estadiamento de Neoplasias Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Estadiamento de Neoplasias Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article